India's drug price regulator has fixed retail prices for 30 essential medications used to treat diabetes, high blood pressure, and heart disease, with prices expected to reach consumers within three months. The move aims to reduce catastrophic healthcare spending—surveys show 38% of Indian households with diabetic members face severe out-of-pocket costs—and improve medication access and adherence across the country.